Could your pain be related to Rheumatoid Arthritis?
Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.
Having trouble identifying pills? Try the Pill Identifier
Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.
Worried about drug interactions? Use the Interactions Checker
The drug interactions tool allows you to check for drug-drug and drug-food interactions.
Discover treatment options with the new Symptom Checker
This interactive decision guide helps identify the underlying cause of common symptoms.
Custom search for Medical Transcriptionists?
Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.
Welcome to Drugs.com
Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.
- A to Z Drug List
- Drugs by Condition
- Pill Identifier
- Drug Side Effects
- Drug Dosage
- Interactions Checker
- News & Articles
- FDA Drug Alerts
- New Drug Approvals
- New Drug Applications
- Drug Imprint Codes
- International Drugs
- Drugs by Category
- Pregnancy Warnings
- Emergency Contraception
- Inactive Ingredients
- Video Center
- MedFacts Drug Information
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- MedFacts Natural Products
- FDA Professional Information
- A-Z Drug Facts (Facts & Comparisons)
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- MedFacts Natural Products
Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following subarachnoid hemorrhage.
Breo Ellipta (fluticasone and vilanterol) is a once-a-day inhaled corticosteroid/long-acting beta2 agonist (LABA) combination indicated for ...
Liptruzet (atorvastatin and ezetimibe) is a statin (HMG-CoA reductase inhibitor) and cholesterol absorption inhibitor combination ...
(Not yet approved)
Simeprevir is an investigational NS3/4A protease inhibitor in development for the treatment of chronic hepatitis C.
Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor in development for the treatment of advanced renal cell ...
Trametinib is a MEK inhibitor in development for the treatment of unresectable or metastatic melanoma with BRAF V600 mutations.
Daily Medical NewsRSS
SATURDAY, May 18 -- Just a few extra cups of coffee each month might help prevent the development of an autoimmune liver disease known as primary sclerosing cholangitis (PSC), a new study suggests. Investigators from the Mayo Clinic in Rochester, Minn., found that drinking coffee was associated with a reduced risk of developing the disease, which can lead to cirrhosis of the liver, liver failure...
SATURDAY, May 18 -- A new device that gives doctors a better view during colonoscopies may help them miss fewer suspicious growths during those exams, a new study shows. Colonoscopies are the recommended screening tests for colorectal cancer, which is the second leading cancer killer of men and women in the United States. To perform a colonoscopy, doctors use a long, flexible tube with a camera...
SATURDAY, May 18 -- Vitamin D supplements may help those with Crohn's disease overcome the fatigue and decreased muscle strength associated with the inflammatory bowel disease, according to new research. Extra vitamin D "was associated with significantly less physical, emotional and general fatigue, greater quality of life and the ability to perform activities of daily living," said Tara Raftery,...
Latest Pharma Industry NewsRSS
May 15, 2013 -- The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for men whose cancer has spread after receiving medical or surgical therapy to lower testosterone. Prostate cancer forms in a gland in...
May 15, 2013 -- The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis. Simponi works by blocking tumor necrosis factor (TNF), which plays an important role in causing abnormal inflammatory and immune responses. Previously approved to treat rheumatoid arthritis, psoriatic arthritis and...
May 15, 2013 -- The U.S. Food and Drug Administration today approved the first generic versions of Zomig and Zomig-ZMT tablets. Zomig (zolmitriptan) belongs to the class of drugs called triptans, and is indicated for the acute treatment of migraine with or without aura in adults. Zomig was first approved in tablet form in November 1997, and Zomig-ZMT orally disintegrating tablets followed in...
Latest Additions to Drugs.com
The latest U.S. drug sales data has been released by Drugs.com. The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka’s second generation antipsychotic, and Nexium, AstraZeneca’s leading acid blocker, rank as the top two drugs by sales for the fourth quarter in a row. Both agents ...
We are extremely proud to announce that Drugs.com has been nominated for the prestigious Webby Awards. Kudos to the hard working team! This is their fourth nomination in five years. To yet again be judged among the Internet’s top 5 health web sites is indeed an honor. But wait, there’s more… we need your vote! The ...
Today we are officially launching a new consumer tool to join other leading Drugs.com apps – the Drugs.com Medication Guide. Patients and caregivers will have instant access to their most recent personal medication records, the latest advice on drug therapy and medical conditions, and breaking health news tailored to their needs. In addition, consumers can ...